The serological prevalence of Coxiella burnetii antibodies in sheep and goats in northern Greece  by Pape, M. et al.
10.1111/j.1469-0691.2008.02159.x
The serological prevalence of Coxiella burnetii antibodies in sheep and
goats in northern Greece
M. Pape1, E. G. Bouzalas2, G. S. Koptopoulos2, K. Mandraveli1, M. Arvanitidou-Vagiona3, P. Nikolaidis4
and St. Alexiou-Daniel1
1Laboratory of Infectious Diseases, Department of Microbiology, School of Medicine, AHEPA
University Hospital of Thessaloniki, 2Laboratory of Microbiology and Infectious Diseases, Veterinary
School, 3Department of Hygiene, Medical School, Aristotle University of Thessaloniki and 41st Internal
Medicine Department, Infectious Diseases Division, AHEPA University Hospital of Thessaloniki,
Thessaloniki, Greece
INTRODUCTION
Q-fever is a worldwide zoonosis caused by
Coxiella burnetii, an obligate intracellular rickett-
sial organism. C. burnetti infections have been
reported in humans, farm animals, pet animals,
wild animals, and arthropods. Among farm ani-
mals, sheep and goats are the major reservoirs of
C. burnetii. They shed microorganisms in their
milk, urine, faeces, and placentas. Infected pla-
cental tissue, postpartum discharges and faeces
are presumed to be the principal sources of
transmission to other animals and to humans.
In humans, the clinical presentation of Q-fever
is very pleomorphic and non-speciﬁc. Infection in
animals is usually asymptomatic, but has been
associated with infertility and abortions. Thus, Q-
fever is of signiﬁcant socio-economic importance
[1].
No epidemiological study has been conducted
before to estimate the prevalence of C. burnetii
antibodies in sheep and goats in northern Greece.
MATERIALS AND METHODS
In total, 615 blood samples were collected from sheep (554)
and goats (61), and tested for C. burnetii antibodies by indirect
immunoﬂuorescence assay. Sampling sites were selected to
represent the whole of northern Greece. The sera were initially
diluted 1 ⁄ 16. The positive sera were further titrated. Positive
and negative control sera were included in all readings.
Antibody titres of 1 : 32 were considered to be positive. Only
IgG antibodies were determined.
RESULTS
Four of 61 goats (6.5%) and 58 of 554 sheep
(10.4%) had antibodies to C. burnetii. Seropositive
animals were present in all prefectures, but
seroprevalence varied widely among them. The
highest percentage of seropositivity in sheep was
observed in the prefectures of Evros (22.0%),
Halkidiki (15.8%), and Imathia (16.8%). An inter-
esting observation was the very low seropreva-
lence in two areas, Kastoria and Florina, where
2.4% and the 4.8% of the sheep were positive,
respectively. The seroprevelance in goats was
more or less similar in all districts. Titres of 1 : 32,
1 : 64, 1 : 128 and 1 : 256 were detected in 34%,
39%, 21% and 6%, respectively.
DISCUSSION
Q-fever was ﬁrst described in 1935 by Edward
Derrick, after he investigated an outbreak of
febrile illness involving abattoir workers in
Queensland, Australia. Q-fever is now known to
be a worldwide zoonosis with highly variable
clinical features.
Domestic ruminants are the major reservoirs of
animals that lead to human disease. Sheep and
goats are infected by ticks (over 40 species are
known), and then transfer C. burnetii in their
excretions. Q-fever occurs in humans who acquire
infection via infectious aerosols that are generated
at relatively long distances from the site of
acquisition. Although animals rarely show any
symptoms of the infection, abortions have been
noted in some cases.
We have not found any previous reports
detailing exposure of sheep to C. burnetii in
northern Greece. In our study, the indirect immu-
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noﬂuorescence assay was used, which is as
sensitive as the ELISA method, but more speciﬁc.
Seropositivity to C. burnetii occurred in about
10% of the animals. More speciﬁcally, a higher
percentage of antibodies was detected in sheep
(10.4%) than in goats (6.5%).
Differences in seropositivity in the animal
population have been observed in other countries.
In the USA, goats have been shown to have a
higher seroprevalence of C. burnetii (41.6%) than
sheep (16.5%) [2]. In southern Croatia, 16.4% of
domestic animals were found to be seropositive
[3]. In Egypt, antibodies were detected in 22.5%
and in 16.8% of sheep and goats, respectively [4].
Seroprevalence analysis in Italy indicated that the
C. burnetii distribution in sheep and goats is very
high (38% and 47% respectively). A considerable
number of Q-fever outbreaks have been observed
in Bosnia and Herzegovina, where sheep and
goats have been shown to be the source of
infection in humans [5].
The present study revealed the presence of
C. burnetii in domestic animals throughout north-
ern Greece. More studies are required to further
characterize the epidemiology of Q-fever infection
in animals and in humans in Greece.
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